Palisade Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.47M Buy
+16,582
New +$7.01M 0.28% 109
2015
Q4
Sell
-5,051
Closed -$391K 532
2015
Q3
$391K Sell
5,051
-304
-6% -$26.9K 0.01% 475
2015
Q2
$486K Sell
5,355
-6,340
-54% -$508K 0.01% 474
2015
Q1
$880K Buy
11,695
+650
+6% +$46.7K 0.02% 406
2014
Q4
$811K Buy
11,045
+219
+2% +$15.4K 0.02% 393
2014
Q3
$763K Sell
10,826
-2,869
-21% -$190K 0.02% 395
2014
Q2
$772K Sell
13,695
-10,957
-44% -$578K 0.02% 387
2014
Q1
$1.29M Buy
24,652
+2,098
+9% +$104K 0.03% 336
2013
Q4
$1.08M Sell
22,554
-8,728
-28% -$403K 0.03% 335
2013
Q3
$1.34M Sell
31,282
-30,817
-50% -$1.2M 0.04% 333
2013
Q2
$2.24M Buy
+62,099
New +$2.4M 0.06% 304

Other funds holding HCA

Palisade Capital Management's HCA Position: Q2 2026 in Review

Palisade Capital Management opened a new position in HCA Healthcare (HCA) in Q2 2026: 16,582 shares worth $6.47M. The stake represents 0.28% of the portfolio and ranks #109 among its holdings. This is a return to the name: Palisade Capital Management previously reported a position in HCA as recently as Q3 2015.

Palisade Capital Management first reported a position in HCA in Q2 2013 and has held it in 11 quarters since. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Palisade Capital Management held 16,582 shares of HCA Healthcare worth $6.47M as of Q2 2026.
  • HCA Healthcare was a new Palisade Capital Management position in Q2 2026.
  • HCA Healthcare made up 0.28% of Palisade Capital Management's portfolio in Q2 2026, its #109 holding.
  • Palisade Capital Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 11 quarters since.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Palisade Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.